Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02189213
Recruitment Status : Terminated
First Posted : July 14, 2014
Last Update Posted : March 10, 2021
Sponsor:
Collaborator:
Columbia University
Information provided by (Responsible Party):
Amir A. Levine, New York State Psychiatric Institute

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Terminated
Actual Primary Completion Date : December 2019
Actual Study Completion Date : December 2019
Certification/Extension First Submitted : February 18, 2021
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 June 22, 2021
July 13, 2021
2 July 30, 2021
August 24, 2021
3 August 30, 2021
(Canceled on September 14, 2021)
September 14, 2021